Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rebecca, Champion"'
Autor:
Michał Taszner, Stefano Luminari, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Poon, Jose Villasboas, Rebecca Champion, Emmanuel Bachy, Stephanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite de Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Tae Min Kim
Publikováno v:
HemaSphere, Vol 7, p e214536e (2023)
Externí odkaz:
https://doaj.org/article/5439b0413b664b68bbe3cb52f1a924ba
Autor:
Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai, Deepa Jagadeesh, Mary J. Lechowicz, Craig Okada, Tatyana A. Feldman, Paola Ghione, Juan P. Alderuccio, Rebecca Champion, Seo-Hyun Kim, Ann Mohrbacher, Kasi V. Routhu, Prajak Barde, Ajit M. Nair, Bradley M. Haverkos
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Tenalisib, a selective phosphoinositide-3-kinase δ/γ, and salt-inducible-kinase-3 inhibitor has shown efficacy and was well-tolerated in patients with T-cell lymphoma (TCL). In vitro studies suggest a synergistic anti-tumor potential for the combin
Externí odkaz:
https://doaj.org/article/e5c3577369044e1e834302358c57d097
Autor:
Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Bergeron, Stephen B. Ting, Jing-Zhou Hou, Achilles Anagnostopoulos, Andrew McDonald, Vidhya Murthy, Takahiro Yamauchi, Jianxiang Wang, Qi Jiang, Yan Sun, Brenda Chyla, Wellington Mendes, Courtney D. DiNardo
Publikováno v:
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710a49439e492a75480f15f52bb4e126
https://doi.org/10.1182/blood.2022016963
https://doi.org/10.1182/blood.2022016963
Publikováno v:
Hand Therapy. 27:105-111
Introduction: This study investigates if the psychological subscale from the STarT Back Screening Tool (STarT Psych-sub) identifies patients at high risk of a poor functional outcome after a trapeziectomy based on modifiable psychological factors. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce62b36980a825cb014d22650c0f38f9
https://doi.org/10.1177/17589983221120839
https://doi.org/10.1177/17589983221120839
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7048a30eddf5ad18755f1aba03ca478
https://doi.org/10.1016/s1470-2045(22)00339-4
https://doi.org/10.1016/s1470-2045(22)00339-4
Autor:
Paolo Strati, Morton Coleman, Rebecca Champion, Shuo Ma, Caterina Patti, Moshe Y. Levy, Izidore S. Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, Lihua E. Budde
Publikováno v:
British Journal of Haematology. 199:76-85
Acalabrutinib, a Bruton tyrosine kinase inhibitor, demonstrated greater selectivity and improved safety versus ibrutinib in a head-to-head trial in relapsed/refractory (R/R) chronic lymphocytic leukaemia. In the R/R marginal zone lymphoma (MZL) cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aff4c2cca2a89983ddc87f53df2f6f0
https://doi.org/10.1111/bjh.18368
https://doi.org/10.1111/bjh.18368
Autor:
Tae Min Kim, Michal Taszner, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Limei Poon, Jose C. Villasboas, Rebecca Champion, Emmanuel Bachy, Stéphanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite De Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Stefano Luminari
Publikováno v:
Blood. 140:2280-2282
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f261ff2156a49b3f5674a51b5c1f7b63
https://doi.org/10.1182/blood-2022-158404
https://doi.org/10.1182/blood-2022-158404
Autor:
Alison Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick Michael Reagan, Nina D. Wagner-Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Ronald L. Dubowy, Aleco D’Andrea, Lei Wang, Leo I. Gordon
Publikováno v:
Journal of Clinical Oncology. 40:7062-7062
7062 Background: Pts with R/R LBCL after first-line (1L) treatment (tx) who are unable to undergo high-dose chemotherapy (HDCT) and HSCT have poor outcomes and limited tx options. PILOT (NCT03483103) evaluated liso-cel, an autologous, CD19-directed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ddbbf4b2067d9ba275f07d80cd9e09f
https://doi.org/10.1200/jco.2022.40.16_suppl.7062
https://doi.org/10.1200/jco.2022.40.16_suppl.7062
Publikováno v:
Perception. 2019 Supplement 2S, Vol. 48, p1-236. 236p.